NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Neurocrine Clinical Site, Bryant, Arkansas, United States

Neurocrine Clinical Site, Little Rock, Arkansas, United States

Neurocrine Clinical Site, Anaheim, California, United States

Neurocrine Clinical Site, Pico Rivera, California, United States

Neurocrine Clinical Site, San Diego, California, United States

Neurocrine Clinical Site, Sherman Oaks, California, United States

Neurocrine Clinical Site, Torrance, California, United States

Neurocrine Clinical Site, Hollywood, Florida, United States

Neurocrine Clinical Site, Miami Lakes, Florida, United States

Neurocrine Clinical Site, Atlanta, Georgia, United States

Neurocrine Clinical Site, Decatur, Georgia, United States

Neurocrine Clinical Site, Snellville, Georgia, United States

Neurocrine Clinical Site, Chicago, Illinois, United States

Neurocrine Clinical Site, Gaithersburg, Maryland, United States

Neurocrine Clinical Site, Watertown, Massachusetts, United States

Neurocrine Clinical Site, Marlton, New Jersey, United States

Neurocrine Clinical Site, Staten Island, New York, United States

Neurocrine Clinical Site, The Bronx, New York, United States

Neurocrine Clinical Site, Austin, Texas, United States

Neurocrine Clinical Site, DeSoto, Texas, United States

Neurocrine Clinical Site, Houston, Texas, United States